{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:03:02Z","timestamp":1694415782655},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T00:00:00Z","timestamp":1216339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00277-008-0550-4","type":"journal-article","created":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T10:34:08Z","timestamp":1216290848000},"page":"43-50","source":"Crossref","is-referenced-by-count":2,"title":["Commercial LightCycler\u00ae-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2\/IgH rearrangement in patients with follicular lymphoma"],"prefix":"10.1007","volume":"88","author":[{"given":"M.","family":"Kornacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kornacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,18]]},"reference":[{"key":"550_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.3110950","volume":"237","author":"MS Lee","year":"1987","unstructured":"Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA (1987) Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 237:175\u2013178 doi: 10.1126\/science.3110950","journal-title":"Science"},{"key":"550_CR2","first-page":"117","volume-title":"Important advances in oncology, V.T.H","author":"JG Gribben","year":"1994","unstructured":"Gribben JG, Nadler LM (1994) Detection of minimal residual disease in patients with lymphoma using the polymerase chain reaction. In: De Vita S, Rosenberg SA (eds) Important advances in oncology, V.T.H. Lippincott, Philadelphia, pp 117\u2013129"},{"key":"550_CR3","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood.V81.12.3449.3449","volume":"81","author":"JG Gribben","year":"1993","unstructured":"Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M et al (1993) Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81:3449\u20133457","journal-title":"Blood"},{"key":"550_CR4","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood.V91.8.2955.2955_2955_2960","volume":"91","author":"A Lopez-Guillermo","year":"1998","unstructured":"Lopez-Guillermo A, Cabanillas F, McLaughlin P, Smith T, Hagemeister F, Rodriguez MA et al (1998) The clinical significance of molecular response in indolent follicular lymphomas. Blood 91:2955\u20132960","journal-title":"Blood"},{"issue":"Suppl 1","key":"550_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/11.suppl_1.S137","volume":"11","author":"A Lopez-Guillermo","year":"2000","unstructured":"Lopez-Guillermo A, Cabanillas F, McLaughlin P, Smith T, Hagemeister F, Rodriguez MA et al (2000) Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series. Ann Oncol 11(Suppl 1):137\u2013140 doi: 10.1023\/A:1008369623425","journal-title":"Ann Oncol"},{"key":"550_CR6","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2004.10.054","volume":"22","author":"P Corradini","year":"2004","unstructured":"Corradini P, Ladetto M, Zallio F, Astolfi M, Rizzo E, Sametti S et al (2004) Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes. J Clin Oncol 22:1460\u20131468 doi: 10.1200\/JCO.2004.10.054","journal-title":"J Clin Oncol"},{"key":"550_CR7","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","volume":"94","author":"AS Freedman","year":"1999","unstructured":"Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC et al (1999) Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 94:3325\u20133333","journal-title":"Blood"},{"key":"550_CR8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood.V99.3.856","volume":"99","author":"A Rambaldi","year":"2002","unstructured":"Rambaldi A, Lazzari M, Manzoni C, Carlotti E, Arcaini L, Baccarani M et al (2002) Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood 99:856\u2013862 doi: 10.1182\/blood.V99.3.856","journal-title":"Blood"},{"key":"550_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1701300","volume":"22","author":"N Neuhoff von","year":"1998","unstructured":"von Neuhoff N, Dreger P, Suttorp M, Marget M, Kell S, Schmitz N (1998) Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma. Bone Marrow Transplant 22:161\u2013166 doi: 10.1038\/sj.bmt.1701300","journal-title":"Bone Marrow Transplant"},{"key":"550_CR10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.leukres.2005.10.001","volume":"30","author":"C Schmitt","year":"2006","unstructured":"Schmitt C, Balogh B, Grundt A, Buchholtz C, Leo A, Benner A et al (2006) The bcl-2\/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Leuk Res 30:745\u2013750 doi: 10.1016\/j.leukres.2005.10.001","journal-title":"Leuk Res"},{"key":"550_CR11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0609.2004.00391.x","volume":"74","author":"S Martin","year":"2005","unstructured":"Martin S, Fischer C, Free M, Kurreck B, Stockinger H, Fenk R et al (2005) LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy. Eur J Haematol 74:282\u2013292 doi: 10.1111\/j.1600-0609.2004.00391.x","journal-title":"Eur J Haematol"},{"key":"550_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.leu.2402329","volume":"16","author":"C Schoch","year":"2002","unstructured":"Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A, Berger U et al (2002) Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia 16:53\u201359 doi: 10.1038\/sj.leu.2402329","journal-title":"Leukemia"},{"key":"550_CR13","first-page":"1706","volume":"90","author":"AJ Darby","year":"2005","unstructured":"Darby AJ, Lanham S, Soubeyran P, Johnson PW (2005) Variability of quantitative polymerase chain reaction detection of the bcl-2\u2013IgH translocation in an international multicenter study. Haematologica 90:1706\u20131707","journal-title":"Haematologica"},{"key":"550_CR14","first-page":"2271","volume":"6","author":"J Limpens","year":"1991","unstructured":"Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ et al (1991) Bcl-2\/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271\u20132276","journal-title":"Oncogene"},{"key":"550_CR15","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","volume":"85","author":"J Limpens","year":"1995","unstructured":"Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ et al (1995) Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528\u20132536","journal-title":"Blood"},{"key":"550_CR16","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1073\/pnas.91.19.8910","volume":"91","author":"Y Liu","year":"1994","unstructured":"Liu Y, Hernandez AM, Shibata D, Cortopassi GA (1994) BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A 91:8910\u20138914 doi: 10.1073\/pnas.91.19.8910","journal-title":"Proc Natl Acad Sci U S A"},{"key":"550_CR17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2001.19.2.420","volume":"19","author":"KE Summers","year":"2001","unstructured":"Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J (2001) Frequency of the Bcl-2\/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 19:420\u2013424","journal-title":"J Clin Oncol"},{"key":"550_CR18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood-2002-03-0887","volume":"100","author":"L Dolken","year":"2002","unstructured":"Dolken L, Schuler F, Dolken G (2002) Frequency of BCL-2\/J(H) translocation in healthy males exposed to low-level radiation in comparison to age-matched health controls. Blood 100:1513\u20131514 doi: 10.1182\/blood-2002-03-0887","journal-title":"Blood"},{"key":"550_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1044-579X(03)00016-6","volume":"13","author":"F Schuler","year":"2003","unstructured":"Schuler F, Hirt C, Dolken G (2003) Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol 13:203\u2013209 doi: 10.1016\/S1044-579X(03)00016-6","journal-title":"Semin Cancer Biol"},{"key":"550_CR20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1525-1578(10)60537-5","volume":"6","author":"A Bowman","year":"2004","unstructured":"Bowman A, Jones D, Medeiros LJ, Luthra R (2004) Quantitative PCR detection of t(14;18) bcl-2\/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples. J Mol Diagn 6:396\u2013400","journal-title":"J Mol Diagn"},{"key":"550_CR21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00277-003-0762-6","volume":"82","author":"CM Mandigers","year":"2003","unstructured":"Mandigers CM, Meijerink JP, Van\u2019t Veer MB, Mensink EJ, Raemaekers JM (2003) Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma. Ann Hematol 82:743\u2013749 doi: 10.1007\/s00277-003-0762-6","journal-title":"Ann Hematol"},{"key":"550_CR22","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2006-04-016725","volume":"108","author":"R Forstpointner","year":"2006","unstructured":"Forstpointner R, Unterhalt M, Dreyling M, Bock HP, Repp R, Wandt H et al (2006) Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG). Blood 108:4003\u20134008 doi: 10.1182\/blood-2006-04-016725","journal-title":"Blood"},{"key":"550_CR23","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","volume":"103","author":"M Ghielmini","year":"2004","unstructured":"Ghielmini M, Schmitz SF, Cogliatti SB, Pichert G, Hummerjohann J, Waltzer U et al (2004) Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly \u00d7 4 schedule. Blood 103:4416\u20134423 doi: 10.1182\/blood-2003-10-3411","journal-title":"Blood"},{"key":"550_CR24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00277-006-0113-5","volume":"85","author":"F Neumann","year":"2006","unstructured":"Neumann F, Harmsen S, Martin S, Kronenwett R, Kondakci M, Aivado M et al (2006) Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin\u2019s lymphoma. Ann Hematol 85:530\u2013534 doi: 10.1007\/s00277-006-0113-5","journal-title":"Ann Hematol"},{"key":"550_CR25","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","volume":"108","author":"MH Oers van","year":"2006","unstructured":"van Oers MH, Klasa R, Marcus RE, Wolf M, Kimby E, Gascoyne RD et al (2006) Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial. Blood 108:3295\u20133301 doi: 10.1182\/blood-2006-05-021113","journal-title":"Blood"},{"key":"550_CR26","first-page":"2497","volume":"9","author":"E Fernandez-Ruiz","year":"2003","unstructured":"Fernandez-Ruiz E, Cabrerizo M, Ortega M, Blas C, Llamas P, Santos-Roncero M et al (2003) High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide\u2013vincristine\u2013prednisone plus interferon alpha 2b. Clin Cancer Res 9:2497\u20132503","journal-title":"Clin Cancer Res"},{"key":"550_CR27","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1023\/A:1008399623564","volume":"11","author":"P Brice","year":"2000","unstructured":"Brice P, Simon D, Bouabdallah R, Belanger C, Haioun C, Thieblemont C et al (2000) High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol. Ann Oncol 11:1585\u20131590 doi: 10.1023\/A:1008399623564","journal-title":"Ann Oncol"},{"key":"550_CR28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1200\/JCO.1995.13.5.1073","volume":"13","author":"JE Hardingham","year":"1995","unstructured":"Hardingham JE, Kotasek D, Sage RE, Gooley LT, Mi JX, Dobrovic A et al (1995) Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin\u2019s lymphoma. J Clin Oncol 13:1073\u20131079","journal-title":"J Clin Oncol"},{"key":"550_CR29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2002-02-0621","volume":"100","author":"M Ladetto","year":"2002","unstructured":"Ladetto M, Corradini P, Vallet S, Benedetti F, Vitolo U, Martelli M et al (2002) High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood 100:1559\u20131565 doi: 10.1182\/blood-2002-02-0621","journal-title":"Blood"},{"key":"550_CR30","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.leu.2401242","volume":"12","author":"M Moos","year":"1998","unstructured":"Moos M, Schulz R, Martin S, Benner A, Haas R (1998) The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin\u2019s lymphoma. Leukemia 12:1971\u20131976 doi: 10.1038\/sj.leu.2401242","journal-title":"Leukemia"},{"key":"550_CR31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood.V97.1.101","volume":"97","author":"P Colombat","year":"2001","unstructured":"Colombat P, Salles G, Brousse N, Eftekhari P, Soubeyran P, Delwail V et al (2001) Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood 97:101\u2013106 doi: 10.1182\/blood.V97.1.101","journal-title":"Blood"},{"key":"550_CR32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood.V98.4.940","volume":"98","author":"CM Mandigers","year":"2001","unstructured":"Mandigers CM, Meijerink JP, Mensink EJ, Tonnissen EL, Hebeda KM, Bogman MJ et al (2001) Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma. Blood 98:940\u2013944 doi: 10.1182\/blood.V98.4.940","journal-title":"Blood"},{"key":"550_CR33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bmt.1704130","volume":"32","author":"CC Chang","year":"2003","unstructured":"Chang CC, Bredeson C, Juckett M, Logan B, Keever-Taylor CA (2003) Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course. Bone Marrow Transplant 32:287\u2013291 doi: 10.1038\/sj.bmt.1704130","journal-title":"Bone Marrow Transplant"},{"key":"550_CR34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2353\/jmoldx.2006.050050","volume":"8","author":"N Pennell","year":"2006","unstructured":"Pennell N, Woods A, Reis M, Buckstein R, Spaner D, Imrie K et al (2006) Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction. J Mol Diagn 8:40\u201350 doi: 10.2353\/jmoldx.2006.050050","journal-title":"J Mol Diagn"},{"key":"550_CR35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/030089160509100111","volume":"91","author":"RA Perego","year":"2005","unstructured":"Perego RA, Cairoli R, Cornacchini G, Bianchi C, Corizzato M, Tresoldi E et al (2005) The role of quantitative polymerase chain reaction in the management of follicular lymphoma patients. Tumori 91:59\u201366","journal-title":"Tumori"},{"key":"550_CR36","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2004-06-2490","volume":"105","author":"A Rambaldi","year":"2005","unstructured":"Rambaldi A, Carlotti E, Oldani E, Della Starza I, Baccarani M, Cortelazzo S et al (2005) Quantitative PCR of bone marrow BCL2\/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma. Blood 105:3428\u20133433 doi: 10.1182\/blood-2004-06-2490","journal-title":"Blood"},{"key":"550_CR37","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.leukres.2006.01.014","volume":"30","author":"C Schmitt","year":"2006","unstructured":"Schmitt C, Grundt A, Buchholtz C, Scheuer L, Benner A, Hensel M et al (2006) One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2\/IgH positive cells: Is the end of molecular monitoring near? Leuk Res 30:1563\u20131568 doi: 10.1016\/j.leukres.2006.01.014","journal-title":"Leuk Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0550-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-008-0550-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0550-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T02:12:34Z","timestamp":1588817554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-008-0550-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,18]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0550-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,18]]}}}